Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has received an average recommendation of “Hold” from the twelve research firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $14.6667.
ARDT has been the subject of several analyst reports. Guggenheim lowered their price objective on Ardent Health from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, November 18th. JPMorgan Chase & Co. decreased their target price on Ardent Health from $15.00 to $12.00 and set a “neutral” rating for the company in a research note on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ardent Health in a report on Monday, December 22nd. Morgan Stanley reissued an “equal weight” rating and set a $12.00 price objective (down previously from $22.00) on shares of Ardent Health in a report on Friday, November 14th. Finally, Mizuho reduced their price objective on shares of Ardent Health from $20.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, December 18th.
Get Our Latest Stock Analysis on ARDT
Institutional Investors Weigh In On Ardent Health
Ardent Health Trading Up 2.9%
Shares of NYSE:ARDT opened at $9.23 on Thursday. Ardent Health has a 52 week low of $8.28 and a 52 week high of $17.34. The company’s 50 day moving average is $10.94 and its two-hundred day moving average is $12.19. The company has a market cap of $1.32 billion, a PE ratio of 6.37, a P/E/G ratio of 7.59 and a beta of 0.77. The company has a current ratio of 2.08, a quick ratio of 1.95 and a debt-to-equity ratio of 0.67.
Ardent Health (NYSE:ARDT – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.10. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.55 billion. Ardent Health had a net margin of 3.24% and a return on equity of 19.02%. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. Equities analysts predict that Ardent Health will post 1.23 earnings per share for the current fiscal year.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Further Reading
- Five stocks we like better than Ardent Health
- Wall Street Stockpicker Names #1 Stock of 2026
- [URGENT!] SpaceX Going Public! – Pre-IPO Action
- ALERT: Drop these 5 stocks before January 2026!
- “$6.6 Trillion Of Customer Bank Deposits At Risk”
- Washington prepares for war
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
